MedStar Heart & Vascular Institute First to Implant Device in Clinical Trial

The clinical trial is investigating a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation. The device, called the WATCHMAN FLX™, is being investigated for greater flexibility and safety while positioning the device in the left atrial appendage. Read more.



Click below to go to our Newsroom.

Eva Hochberger
Marketing & Communications Manager
Phone: 301-560-2917
[email protected]